Correspondence 0001285550-23-000119 from ClearPoint Neuro, Inc. (CLPT) (CIK 0001285550) (CLPT)
ClearPoint Neuro, Inc. (CLPT) (CIK 0001285550)
Date: Nov. 17, 2023 · CIK: 0001285550 · Accession: 0001285550-23-000119
AI Filing Summary & Sentiment
File numbers found in text: 333-275476
Letter
Document
CLEARPOINT NEURO, INC.
120 S. Sierra Avenue, Suite 100
Solana Beach, California 92075
November 17, 2023
VIA EDGAR
U.S. Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
Attention: Jessica Ansart
Re: ClearPoint Neuro, Inc.
Registration Statement on Form S-3 (File No. 333-275476)
Request for Acceleration
Ladies and Gentlemen:
Pursuant to Rule 461 promulgated under the Securities Act of 1933, as amended, ClearPoint Neuro, Inc. (the “Company”) hereby requests that the Securities and Exchange Commission (the “Commission”) accelerate the effective date of the Company’s Registration Statement on Form S-3 (File No. 333-275476) (the “Registration Statement”), so that it will be declared effective at 4:00 p.m. Eastern Time on November 20, 2023, or as soon as possible thereafter. The Company hereby authorizes Richard Mattern, counsel to the Company, to orally modify or withdraw this request for acceleration.
It would be appreciated if, as soon as the Registration Statement is declared effective, you would inform Richard Mattern of Bass, Berry & Sims PLC, counsel to the Company, at (901) 543-5933.
Sincerely,
CLEARPOINT NEURO, INC.
Show Raw Text
CORRESP
1
filename1.htm
Document
CLEARPOINT NEURO, INC.
120 S. Sierra Avenue, Suite 100
Solana Beach, California 92075
November 17, 2023
VIA EDGAR
U.S. Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
Attention: Jessica Ansart
Re: ClearPoint Neuro, Inc.
Registration Statement on Form S-3 (File No. 333-275476)
Request for Acceleration
Ladies and Gentlemen:
Pursuant to Rule 461 promulgated under the Securities Act of 1933, as amended, ClearPoint Neuro, Inc. (the “Company”) hereby requests that the Securities and Exchange Commission (the “Commission”) accelerate the effective date of the Company’s Registration Statement on Form S-3 (File No. 333-275476) (the “Registration Statement”), so that it will be declared effective at 4:00 p.m. Eastern Time on November 20, 2023, or as soon as possible thereafter. The Company hereby authorizes Richard Mattern, counsel to the Company, to orally modify or withdraw this request for acceleration.
It would be appreciated if, as soon as the Registration Statement is declared effective, you would inform Richard Mattern of Bass, Berry & Sims PLC, counsel to the Company, at (901) 543-5933.
Sincerely,
CLEARPOINT NEURO, INC.
By: /s/ Danilo D’Alessandro
Name: Danilo D’Alessandro
Title: Chief Financial Officer